New Metabolic Disease Articles from our Partners at Consultant 360

Fenofibrate May Reduce Cardiovascular Disease Risk in Statin-Treated Type 2 Diabetes Patients

A new study sought to determine if fenofibrate combined with statin treatment reduced the risk of CV disease in patients with type 2 diabetes who have hypertriglyceridemia and LDL-C.

http://bit.ly/2hOBIZY

“Christmas Holiday Effect:” Increase in Cardiac-Related Deaths Around the Holidays

A recent study sought to test whether cardiac related mortality increased during the holiday season in New Zealand.

http://bit.ly/2iLKG8O

Could Saturated Fats Be Less Harmful Than Previously Thought?

New research suggests that saturated fats might not be as detrimental to heart and overall health as previously believed.

http://bit.ly/2izEYHB

Insulin Resistance is Linked to Adverse Cardiac Function Even Before Diabetes Development

A recent study examined the relationship between glucose homeostasis and measures of cardiac structure and function in patients with prediabetes, diabetes, and uncontrolled diabetes.

http://bit.ly/2ivHDnG

Beta-Blockers Decrease Mortality Following MI

New study examined the effects of beta-blockers on mortality and functional decline in nursing home residents after an acute myocardial infraction.

http://bit.ly/2hMlu0o